Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Clinical trial NCT07230288 · RECRUITING
Trial details
- NCT number
- NCT07230288
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-23
- Primary completion
- 2029-09-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.